On May 20-23, 2010, the 4^th Critical Care Medicine Conference of Chinese Medical Association was successfully held in Wuhan Science & Technology Convention Center, where more than 3,000 participating doctors from various places of China were welcomed. During this conference, the latest clinical progress of national Critical Care Medicine was announced, the subject leading-edge issues were discussed, emphasizing on the subject construction and basic training, while famous experts of Critical Care Medicine were invited to give specific reports.

Simcere Pharma, making use of this conference, introduced Biapenem for Injection, the anti-moderate and severe infection medicine to the participating experts. The participating doctors showed great interests in it, a number of experts even initiatively requested to leave contact information, hoping Simcere’s staff would contact them after the conference.

Mr. Yang Xiaohua, Vice President of Marketing and Mr. Gu Jian, Deputy General Manager of Marketing Department went all the way to the conference venue, participating in the satellite meeting held for Biapenem for Injection after the conference. Professor Liu Dawei of Peking Union Medical College Hospital, ICU’s National chairman of committee was invited to serve as the chairman of this satellite meeting, while Professor Chen Dechang, ICU Directorof Shanghai Changzheng Hospital acted as the meeting’s speaker. Strong meeting lineup and meticulous preparation made this meeting cared by many experts, with 400 seats in the meeting hall being all occupied, Professor Chen Dechang’s wonderful speech and Professor Liu Dawei's incisive comments enabled involved doctors to have more updated and in-depth understanding on Biapenem for Injection. This satellite meeting’s convening allowed more clinicians across the country to recognize the position that Biapenem for Injection takes, as the latest carbapenem drugs domestically in ICU antibiotic application strategy.